<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Markets — Leocyte</title>
  <meta name="description" content="Primary markets: India, Brazil, Portugal, Mexico and Colombia — Leocyte market insights for BD&L and commercialization." />
  <link rel="stylesheet" href="assets/css/styles.css" />
  <script defer src="cookie-consent.js"></script>
</head>
<body class="layout">
  <a class="skip" href="#main">Skip to main content</a>
  <header class="site-header">
    <div class="container">
      <a class="logo" href="/"><strong>Leocyte</strong></a>
      <nav aria-label="Main navigation">
        <ul class="nav">
          <li><a href="about.html">About</a></li>
          <li><a href="services.html">Services</a></li>
          <li><a href="markets.html" aria-current="page">Markets</a></li>
          <li><a href="privacy.html">Privacy</a></li>
        </ul>
      </nav>
      <a class="cta small" href="mailto:AlloAllo@leocyte.com">Talk to our market leads</a>
    </div>
  </header>

  <main id="main" class="container" role="main">
    <h1>Markets — Local intelligence, regional impact</h1>
    <p class="lede">We combine centralized strategy with on-the-ground market leads who understand regulatory pathways, payer landscapes and distribution networks in each country.</p>

    <section aria-labelledby="india">
      <h2 id="india">India</h2>
      <p>Large, cost-sensitive market with strong manufacturing capacity. Regulatory timelines are evolving — biosimilars and generics remain high-opportunity categories.</p>
    </section>

    <section aria-labelledby="brazil">
      <h2 id="brazil">Brazil</h2>
      <p>Public payer (SUS) considerations are central. Access requires pricing and reimbursement strategies that engage both public tenders and private channels.</p>
    </section>

    <section aria-labelledby="portugal">
      <h2 id="portugal">Portugal</h2>
      <p>EU regulatory alignment and strong clinical research networks make Portugal an attractive launch pad for EU entry.</p>
    </section>

    <section aria-labelledby="mexico">
      <h2 id="mexico">Mexico</h2>
      <p>Distribution complexity across public and private systems; opportunity for fast-moving launches with the right local partners.</p>
    </section>

    <section aria-labelledby="colombia">
      <h2 id="colombia">Colombia</h2>
      <p>Rapidly modernizing market access routes and growing appetite for partnerships that reduce cost while improving outcomes.</p>
    </section>

    <p class="muted">Want a full market brief for any of these countries? <a href="mailto:AlloAllo@leocyte.com">Contact our market leads</a>.</p>
  </main>

  <footer class="site-footer">
    <div class="container footer-grid">
      <div>
        <strong>Leocyte</strong><br/>
        Email: <a href="mailto:AlloAllo@leocyte.com">AlloAllo@leocyte.com</a>
      </div>
      <nav aria-label="Footer">
        <ul class="footer-nav"><li><a href="privacy.html">Privacy</a></li></ul>
      </nav>
      <div class="small muted">© <span id="year4"></span> Leocyte — All rights reserved</div>
    </div>
  </footer>

  <script>document.getElementById('year4').textContent = new Date().getFullYear();</script>
</body>
</html>
